Nucleic Acid Testing Market Competitive Landscape, 2019-2023: Strategic Assessments of Leading Suppliers

July 2019 | 549 pages | ID: NF719530FDCEN
Venture Planning Group

Abstracts

This 549-page report presents an overview of the clinical significance and market needs for major current and emerging NAT assays, as well as extensive listings of companies developing and marketing innovative technologies and products.

This report also presents strategic assessments of current and emerging suppliers of nucleic acid testing products, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.

Contains 549 pages and 22 tables

Contents

Microbiology/Infectious Diseases
    a. Overview
    b. Major Infectious Diseases
    AIDS
      Structure and Composition
      Classification
      AIDS Origins
      Animal Lentivirus Systems
      Virus Receptors
      HIV Infections in Humans
    Pathogenesis and Pathology
      CD4T Lymphocytes and Memory Cells
      Monocytes and Macrophages
      Lymphoid Organs
      Neural Cells
      Viral Coinfections
    Clinical Findings
      Plasma Viral Load
      Pediatric AIDS
    Neurologic Disease
    Opportunistic Infections
    Cancer
      Immunity
    Virus Isolation
    Serology
    Viral Nucleic Acid/Antigen Detection
      Epidemiology
    Worldwide Spread of AIDS
    United States
    Routes of Transmission
      DNA Probes
    Overview
    Quantitative PCR
    In Situ PCR
    Needed Improvements
      Viral Load/Drug Resistance Testing
      Genotype and Phenotype Testing
      Blood Banking Considerations
    Adenovirus
      Background
      Diagnostic Tests
      Vaccines and Drugs
      Adeno-Associated Viruses (AAV)
    Anthrax/Bacillus Anthracis
      Background
      Diagnostic Tests
      Vaccines and Drugs
    Babesiosis
      Background
    BEA and Other Bartonella Diseases
      Background
      Diagnostic Tests
      Vaccines and Drugs
    Chagas Disease
      Background
    Campylobacter
      Background
      Diagnostic Tests
    Culture Identification
      Vaccines and Drugs
    Chlamydia
      Background
    Chlamydia psittaci
    Chlmaydia pneumoniae
    Chlamydia trachomatis
      Diagnostic Tests
      Vaccines and Drugs
    Creutzfeldt-Jakob’s Disease
      Background
      Blood Transmission
      Diagnostic Tests
      Major Commercial and Academic Players
Bayer
    Disease Sciences/Bio Tec Global
    Imperial College School of Medicine
Ortho-Clinical Diagnostics
    Pall
    ProMetic Life Sciences
Proteome Sciences/Idexx
    Q-One Biotech
    Serono
    U.S. Agricultural Research Service
      Drugs
      Vaccines
    Cytomegalovirus
      Background
    Chorioretinitis
    Gastrointestinal
    Central Nervous System Disease
      Diagnostic Tests
      Vaccines and Drugs
    Ebola Virus
      Background
    Epidemiology
    Clinical Syndromes
      Diagnostic Tests
      Vaccines and Drugs
    EchoVirus
      Background
    Acute Aseptic Meningitisis
    Encephalitis
    Exanthems
    Respiratory Disease
    Myopericarditis
    Neonatal Infections
      Diagnostic Tests
      Vaccines and Drugs
    Encephalitis
      Background
      Diagnostic Tests
      Vaccines and Drugs
    Enteroviruses
      Background
      Diagnostic Tests
    Viral Isolation and Identification
    Antibody Tests
      Vaccines and Drugs
    Epstein-Barr Virus
      Background
      Diagnostic Tests
      Vaccines and Drugs
    Gonorrhea
      Background
      Diagnostic Tests
      Vaccines and Drugs
    Hepatitis
      Hepatitis A
      Hepatitis B
    Structure and Composition
    Replication
      Hepatitis C
      Hepatitis D (Delta)
      Hepatitis E
      Hepatitis G
      Hepatitis Infections Pathology
      Clinical Findings
      Laboratory Tests
    Hepatitis A
    Hepatitis B
    Hepatitis C
    Hepatitis D
    Hepatitis E
      Virus-Host Immune Reactions
      Epidemiology
    Hepatitis A
    Hepatitis B
    Hepatitis C
    Hepatitis D (Delta)
      Vaccines and Drugs
    Herpes Simplex Virus
      Background
      Diagnostic Tests
      Vaccines and Drugs
    Legionella
      Background
      Diagnostic Tests
      Vaccines and Drugs
    Lyme Disease
      Background
    Clinical Description
    Clinical Case Definition
    Laboratory Criteria for Diagnosis
    Case Classification
      Diagnostic Tests
      Vaccines and Drugs
    Malaria
    Mycoplasma
      Background
    Ureaplasma Urealyticum & Mycoplasma Hominis
      Diagnostic Tests
      Vaccines and Drugs
    Papillomaviruses/HPV
      Background
    HPV in Cancer
    Cervical Neoplasm
      Diagnostic Tests
      Vaccines and Drugs
    Prevention
    Parvovirus B19
      Background
    Microbiology
    Epidemiology
    Clinical Syndromes
    Erythema Infectiosum (Slapped Cheek)
    Adult Polyarthropathy
    Transient Aplastic Crisis
    Transient Pancytopenia
    Red Cell Aplasia in Immunocompromised
    Perinatal Infections
      Diagnostic Test
      Vaccines and Drugs
    Pneumonia
      Background
      Diagnostic Tests
      Vaccines and Drugs
    Polyomaviruses
      Background
      Diagnostic Tests
      Vaccines and Drugs
    Salmonellosis
      Background
      Diagnostic Tests
      Vaccines and Drugs
    Shigellosis
      Background
      Diagnostic Tests
      Vaccines and Drugs
    Streptococci
      Background
      Diagnostic Tests
      Vaccines and Drugs
    Group A Streptococci
    Group B Streptococci
    Toxoplasmosis
      Background
      Diagnostic Tests
      Vaccines and Drugs
    Tuberculosis
      Background
      Diagnostic Tests
    Microscopic Characteristics
    Cultural Characteristics
    Skin Tests
    MDRTB
      Vaccines and Drugs
    West Nile Virus
      Background
    Clinical Syndromes
      Diagnostic Tests
      Vaccines and Drugs
    Yersinia
      Background
      Diagnostic Tests
      Vaccines and Drugs
    Antibiotic Susceptibility
Cancer Testing
    a. Overview
    b. Major Cancer Types
    Prostate
    Lung
    Colon and Rectum
    Breast
    Skin
    Uterine
    Leukemia
    Oral
    c. Oncogenes
      Abl/abl-bcr
      AIB1
      BCL-2
      BRCA1
      CD44
      C-fos
      C-myb
      C-myc
      CYP17
      Erb-B
      HPC1
      N-myc
      P40
      P51
      P53
      PIK3CA
      PTI-1
      Ras
      Reg
      Sis
      Src
Genetic Diseases
    a. Overview
    b. Nucleic Acid Amplification
    c. Chromosome Imaging
    d. Genomics Technologies
    e. Proteomics Technologies
    f. Current Pharmacogenomic Tests
    g. Future Pharmacogenomic Testing
    h. Major Diseases
    Achondroplasia
    Autosomal Dominant Polycystic Kidney Disease
    Cancer
    Cosmetogenomics
    Cystic Fibrosis
    Down's Syndrome
    Duchenne and Becker Muscular Dystrophy
    Factor V (Leiden)
    Factor IX Deficiency
    Fragile X Syndrome
    Heart Disease
    Hemochomatosis
    Hemophilia
    Huntington's Disease
    Maternal-Fetal Incompatibility
    Multiple Endocrine Neoplasia
    Phenylketonuria (PKU)
    Polycystic Kidney Disease (PKD)
    Prenatal Screening
    Retinitis Pigmentosa
    Retinoblastoma
    Sickle Cell Anemia
    Spinal Muscular Atrophy
    Vitamin B12 Metabolism
    i. Social Issues and Concerns
Forensic Testing
    a. Overview
    b. Multilocus and Single Locus Probes
    Multilocus Probes
    Single Locus Probes
    PCR and RFLP
    c. The FBI
    d. DNA Profile Data Banks
    U.S.A.
    U.K.
    e. Judicial Implementation
    f. Major Crime Categories
    g. Factors Contributing to the DNA Probe Market Expansion
    Technology Availability
    Use of Hair as Evidence
    h. Wildlife Forensics
Paternity Testing/HLA Typing
Other Applications
    a. Disease Susceptibility Testing
    b. Cardiovascular Diseases
    c. Diabetes
    d. Alzheimer's Disease
    e. Periodontal Disease
    f. Plasma Purification
    g. Organ Transplantation
    h. Water Contamination
    i. Other

COMPETITIVE PROFILES

Abbott
Affymetrix
Agilent Technologies
Applied Gene Technologies
Arca Biopharma
Beckman Coulter/Danaher
Becton Dickinson
Biokit
BioMerieux
Bio-Rad
Biotest
Cepheid
CellMark Forensics/LabCorp
Decode Genetics
Diadexus
Elitech Group
Eiken
Enzo
Exact Sciences
Fujirebio
Grifols
Hologic/Gen-Probe
Illumina
Kreatech/Leica
Li-Cor Biosciences
Monogram Biosciences
Myriad Genetics
Ortho-Clinical Diagnostics
Perkin Elmer/Caliper
Proteome Sciences
Qiagen
Roche
Scienion
Sequenom
Shimadzu
Siemens
Sierra Molecular
Takara Bio
Tecan Group
Thermo Fisher

List Of Tables

LIST OF TABLES

Major Companies Developing or Marketing AIDS Molecular
Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Adenovirus Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Campylobacter Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Chlamydia Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing CMV Molecular
Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing EBV Molecular
Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Gonorrhea Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Hepatitis Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Herpes Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Legionella Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Lyme
Disease Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Mycoplasma Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Papilloma
Virus Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Pneumonia Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Salmonella Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Shigella Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Streptococci Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Toxoplasmosis Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Tuberculosis Molecular Diagnostic And Other Direct Identification Tests
Oncogenes Potential Application in Cancer Diagnosis
Major Companies Developing or Marketing Cancer
Molecular Diagnostic Tests
Major Companies Developing or Marketing Molecular
Diagnostic Test For Genetic Diseases